Autoradiography: High-resolution molecular imaging in pharmaceutical discovery and development

Expert Opinion on Drug Discovery

Volumn 2, Issue 4, 2007, Pages 503-514

  Solon, Eric G ^a  

^a Quest Pharmaceutical Services   (United States)

Author keywords

Autoradiography; Autoradioluminography; Drug discovery and development; Microautoradiography; Pharmacokinetics; Preclinical molecular imaging; Tissue distribution; Whole body autoradiography

Indexed keywords

AMINOSPARK; ANGIOSENSE; ANTIBODY; CARBON; CARBON 11; CARBON 14; CONTRAST MEDIUM; DRUG METABOLITE; FLUORINE 18; GLUCOSE; IODINE 125; LIPOSOME; NANOPARTICLE; NITROGEN 13; NITROGEN 14; NITROGEN 15; OLIGONUCLEOTIDE; ORGANIC COMPOUND; PEPTIDE; PHOSPHORUS; PHOSPHORUS 31; PROSENSE; PROTEIN; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SULFUR 35; TRITIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT; ZIDOVUDINE;

AUTORADIOGRAPHY; CALIBRATION; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG ELUTING STENT; DRUG EXCRETION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG PURITY; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TISSUE LEVEL; ECHOGRAPHY; EX VIVO STUDY; FREEZE DRYING; GAMMA RADIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; IN VIVO STUDY; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; LIQUID SCINTILLATION COUNTING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR IMAGING; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; TISSUE SECTION; WHOLE BODY AUTORADIOGRAPHY;

EID: 34447528682     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.2.4.503     Document Type: Review

References (49)

1. 35S-labeled benzylpenicillin in the body. Acta Radiologica Suppl. (1954) 118:1-110.
2. CARO LG, VAN TUBERGEN RP: High resolution autoradiography. 1. Methods. J. Cell Biol. (1962) 15:173-188.
3. CARO LG: High resolution autoradiography. 2. The problem of resolution. J. Cell Biol. (1962) 15:189-199.
4. STUMPF WE, ROTH LJ: Dry-mounting high-resolution autoradiography. In: Isotopes in experimental pharmacology. Roth L.J. (Ed.), University of Chicago Press, Chicago, Illinois, USA (1965):133-143.
5. STUMPF WE: Addendum 3. Chronology of Development of Techniques, Applications, and Discoveries. In: Drug Localization in Tissues and Cells. IDDC - Press, International Institute of Drug Distribution, Cytopharmacology and Cytotoxicology (2003):145-153.
6. BAKER JRJ: Chapter 5. Light microscopic auto-radiography - diffusible substances. In: Autoradiography: A Comprehensive Overview. Oxford University Press, Royal Microscopical Society, Oxford, UK (1989):28-34.
7. NAGATA T: Techniques and application of microscopic radiography. Histology and Histopathology (1997)12:1091-1124.
8. SOLON EG, KRAUS L: Quantitative whole-body autoradiography in the pharmaceutical. Survey results on study design, methods and regulatory compliance. J. Pharmacol. Toxicol. Methods (2002) 43:73-81.
9. MAAS J, BINDER R, STEINKE W: Quantitative whole-body autoradiography: recomendations for the standardization of the method. Reg. Toxicol. Pharmacol. (2000) 31(2):S15-S21.
10. SOM P, YONEKURA Y, OSTER ZH et al.: Quantitative autoradiography with radiopharmaceuticals. Part 2: applications in radiopharmaceutical research: Concise communication. J. Nucl. Med. (1983) 24(3):238-244.
11. KOLBE H, DIETZEL G: Technical validation of radioluminography systems. Reg. Toxicol. Pharmacol. (2000) 31(2):S5-S14.
12. APPLETON TC: Autoradiography of soluble labeled compounds. J. Royal Microscopical Soc. (1964) 83:277-281.
13. STUMPF WE: Drug Localization in Tissues and Cells. IDDC - Press, International Institute of Drug Distribution, Cytopharmacology and Cytotoxicology (2003).
14. STUMPF WE: Chapter 12. Colocalization - Combined autoradiography and immunohistochecmistry. In: Drug Localization in Tissues and Cells. IDDC - Press, International Institute of Drug Distribution, Cytopharmacology and Cytotoxicology (2003):66-67.
15. STUMPF WE: Chapter 14. Artifacts. In: Drug Localization in Tissues and Cells. IDDC - Press, International Institute of Drug Distribution, Cytopharmacology and Cytotoxicology (2003):74-77.
16. STUMPF WE: Evaluation of Autoradiograms. In: Drug Localization in Tissues and Cells. chapter 10. IDDC - Press, International Institute of Drug Distribution, Cytopharmacology and Cytotoxicology (2003):52-56.
17. SOLON E: Correspondence: Continued discussion of 'Quantitative whole-body autoradiography in the pharmaceutical industry. Survey results on study design, methods, and regulatory compliance'. J. Reg. Toxicol. Methods (2002) 48:187-189.
18. STUMPF W: Correspondence: Limitations and advantages of whole-body autoradiography in the study of tissue distribution of drugs. Response to Dr Solon. J. Reg. Toxicol. Methods (2002) 48:185-186.
19. SHAH VP, MIDHA KK, DIGHE S et al.: Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. (1992) 81(3):309-312.
20. STEINKE W, ARCHIMBAUD Y, BECKA M et al.: Quantitative distribution studies in animals: cross-validation of radioluminography versus liquid-scintillation measurement. Reg. Toxicol. Pharmacol. (2000) 31(2):S33-S44.
21. ROMER W, WU T-D, DUCHAMBON P et al.: Sub-cellular localisation of a 15N-labeled peptide vector using NanoSIMS imaging. Appl. Surface Sci. (2006) 252:6925-6930.
22. COMAR CL: Radioisotopes in Biology and Agriculture: Principles and Practice. McGraw-Hill, New York, USA (1955):1-481.
23. 14C human dosimetry. J. PharmacoL. Toxicol. Methods (2002) 46:83-91.
24. FESTING MFW: Genetic variation in outbred rats and mice and its implications for toxicological screening. J. Exp. Animal Sci. (1993) 35:210-220.
25. Japanese Ministry of Health and Welfare, Medicinal Council 496: Japanese Guidelines for non-clinical pharmacokinetic studies. Japan (1998).
26. LUPETTI A, NIBBERING PH, WELLING MM, PAUWELS EKJ: Radiopharmaceuticals: new antimicrobial agents. Trends Biotechnol. (2003) 21(2):70-73.
27. POTCHOIBA MJ, SMOLAREK TA, BAKER DA, SCHROEDER CM: Effect of an epidermal growth factor (EGFr) tyrosine kinase inhibitor (OSI-774) on thymidine uptake in athymic nude mice bearing human HN5 tumor xenografts. Recent Res. Devel. Drug Metab. Disposition (2004) 2:1-14.
28. 3H]-labeled compounds in drug discovery. Am. Pharm. Rev. (2004) 7:44-48.
29. HESK D., KOHARSKI D, SALUJA S et al.: In: Synthesis and Applications of Isotopically Labeled Compounds. Willey, (1997):439.
30. 125I-labeled modified C-reactive protein in CD-1 mice. Drug Metab. Disposition (1998) 26(10):977-981.
31. VENTURI S, VENTURI M: Iodide, thyroid and stomach carcinogenesis: evolutionary story of a primitive antioxidant? Eur. J. Endocrinol. (1999) 140:371-372.
32. D'ARGY R, SUNDWALL A: Quantitative whole-body autoradioluminography - future strategy for balance and tissue distribution studies. Reg. Toxicol. Pharmacol. (2000) 31(2):S57-S62.
33. CURTIS CG, CROSS SAM, MCCULLOCH RJ, POWELL GM: Whole-Body Autoradiography, Academic Press, London, UK (1981).
34. WADDELL W, MARLOWE C: Autoradiography. In: Drug fate and metabolism, methods and techniques, Volume 1. Garrett ER, Hirtz JL, (Eds.), Marcell Dekker, New York, USA.
35. POTCHOIBA MJ, NOCERINI MR: Utility of whole-body autoradioluminography in drug discovery for the quantification of tritium-labeled drug candidates. Drug Metab. Pharmacokinetics (2004) 32:1190-1198.
36. JENKINS H: Detection and quantification methodology for tritium measurements in whole-body autoradiography. Oral presentation at the Meeting of the European Society for Autoradiography. London, UK (2002).
37. SCHWEITZER A: Tissue self-absorption: Still an Issue? (2004) Oral presentation at the Meeting of the European Society for Autoradiography. Uppsala, Sweden.
38. SCHWEITZER A: The issues of tritium quantification in QWBA. Oral presentation at the Meeting of the Society for Whole-Body Autoradiography. San Diego, USA (2005).
39. LEWSLEY R: Tritium in QWBA studies: To use or not to use, that is the question... Oral presentation at the Meeting of the European Society for Autoradiography. Basel, Switzerland (2006).
40. VIRMANI R, GUAGLIUMI G, FARB A et al.: Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent, should we be cautious? Circulation (2004) 109:701-705.
41. 14C]CS-706, to the arterial elastin of rats. Drug Metab. Pharmacokinetics (2006) 32:1417-1422.
42. COCHET P, BIRCKEL P, BROMETT-PETIT M, BROMET N, WEIL A: Skin distribution of fipronil by microautoradiography following topical administration to the beagle dog. Eur. J. Drug Metab. Pharmacokinetics (1997) 22(3):211-216.
43. SOLON E, BALANI SK, LEE FW: Whole-body autoradiography in drug discovery. Curr. Drug Metab. (2002) 3:451-462.
44. 14C-AZT in fetal and maternal tissues. Poster Abstracts from the 2006 AAPS Annual Meeting, October 29 - November 1 (2006).
45. 14C]-Dalbavancin to New Zealand White Rabbits. Presented at: 16th European Congress of Clinical Microbiology and Infectious Diseases, Nice, France, 1 - 4 April (2006).
46. KINDLMANN G, WEINSTEIN DM, JONES GM, JOHNSON CR, CAPECCHI MR, KELLER C: Practical vessel imaging by computed tomography in live transgenic mouse models for human tumors. Mol. Imaging (2005) 4(4):417-424.
47. HARDWICK MJ, CHEN M-K, BAIDOO K, POMPER MG, GUILTARTE TR: In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: a biomarker for inflammation. Mol. Imaging (2005) 4(4):432-438.
48. MORRIS ED, YODER KK, WANG C et al.: ntPET: a new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter release. Mol. Imaging (2005) 4(4):473-489.
49. GROSS S, PIWNICA-WORMS D: Molecular imaging strategies for drug discovery and development. Curr. Opin. Chem. Biol. (2006) 10(4):334-342.